Boston Scientific (BSX) reached $42.73 at the closing of the latest trading day, reflecting a +1.64%

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Boston Scientific (BSX) concluded the recent trading session at $42.04, signifying a +1.11% move fro

Recently, Zacks.com users have been paying close attention to Boston Scientific (BSX). This makes it

Boston Scientific Corporation (NYSE: BSX - Get Free Report) shares hit a new 52-week low on Thursday

Barclays analyst Christopher Pasquale initiates coverage on Boston Scientific (NYSE:BSX) with a E

What happened Boston Scientific Corporation (NYSE: BSX) said Joseph M. Fitzgerald will become execut

Fitzgerald currently serves as executive vice president and group president, Cardiovascular, Boston

New operating structure designed to increase efficiency and support continued growth MARLBOROUGH, Ma

Boston Scientific (NYSE:BSX) has outperformed the market over the past 15 years by 1.13% on an annua

Elutia Inc. (NASDAQ:ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting bio

Boston Scientific recalls Imager II Angiographic Catheters over tip detachment defect. Learn about p

Wells Fargo analyst Larry Biegelsen maintains Boston Scientific (NYSE:BSX) with a Equal-Weight an

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Oppenheimer analyst Suraj Kalia maintains Boston Scientific (NYSE:BSX) with a Outperform and lowe

Citigroup analyst Joanne Wuensch downgrades Boston Scientific (NYSE:BSX) from Buy to Neutral and

Boston Scientific (NYSE:BSX) has outperformed the market over the past 15 years by 1.01% on an annua

There are dozens of reasons corporate executives sell shares. They may need money to pay taxes, b

Analysts cut targets for CAN, TTAN and BSX, while raising targets for BRZE, VRNS, IMAX, PHVS and CHY

BTIG analyst Marie Thibault maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the pric

Boston Scientific expects a 2026 earnings miss after a cyberattack disrupted global operations. Manu

Based on the information currently available as of the date of this Current Report on Form 8-K, the

Boston Scientific recalls Infinion CX SCS leads following 1,081 injury reports. Health authorities u

Boston Scientific reports a cyber incident disrupting global operations, limiting system access and

Nasdaq 100 falls 0.6% as traders wait on Nvidia and hot July PCE revives September rate-hike bets. E

On August 25, 2026, Boston Scientific Corporation (the "Company") identified a cybersecurity

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

TD Cowen analyst Joshua Jennings reiterates Boston Scientific (NYSE:BSX) with a Buy and maintains

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Boston Scientific (NYSE:BSX) has outperformed the market over the past 15 years by 1.54% on an annua

UBS analyst Patrick Wood maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price t

Citigroup analyst Joanne Wuensch maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the

RBC Capital analyst Kendall Au maintains Boston Scientific (NYSE:BSX) with a Outperform and lower

TD Cowen analyst Joshua Jennings maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the

Canaccord Genuity analyst William Plovanic maintains Boston Scientific (NYSE:BSX) with a Buy and

Truist Securities analyst Richard Newitter maintains Boston Scientific (NYSE:BSX) with a Buy and

Evercore ISI Group analyst Vijay Kumar maintains Boston Scientific (NYSE:BSX) with a Outperform a

Wells Fargo analyst Larry Biegelsen maintains Boston Scientific (NYSE:BSX) with a Equal-Weight an

BTIG analyst Marie Thibault maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the pric

Boston Scientific beat second-quarter estimates but lowered its 2026 sales and earnings outlook as r

Boston Scientific (NYSE:BSX) is looking for Q3 Adj EPS of $0.80-$0.82 vs $0.83 analyst estimate. see

Boston Scientific (NYSE:BSX) lowers FY2026 Adj EPS guidance from $3.34-$3.41 to $3.28-$3.32 vs $3.36

Boston Scientific (NYSE:BSX) reported quarterly earnings of $0.86 per share which beat the analyst c

Boston Scientific (NYSE:BSX) has outperformed the market over the past 15 years by 1.23% on an annua

Oppenheimer analyst Suraj Kalia maintains Boston Scientific (NYSE:BSX) with a Outperform and lowe

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Truist Securities analyst Richard Newitter maintains Boston Scientific (NYSE:BSX) with a Buy and

Mizuho analyst Anthony Petrone maintains Boston Scientific (NYSE:BSX) with a Outperform and lower

July brings a sharp rotation trade in markets as investors shift from top performers to beaten-down

Jim Cramer recommends buying SOFI, and avoiding RIVN and BSX. He also says NIOBF is too speculative,